Call for Applications: Data and Safety Monitoring Board (DSMB) Training Course. Signup Now!

Admin,

Program Objective
This initiative strengthens Africa’s capacity for ethical clinical trial oversight by equipping professionals with advanced skills in safety monitoring. The curriculum prepares participants to contribute to global health security by ensuring rigorous evaluation of vaccines and therapies during development, particularly for emerging infectious diseases.

Program Structure

  • Format: 8-week hybrid learning model blending self-guided modules with live virtual workshops.
  • Facilitators: Global leaders in vaccine safety, biostatistics, and clinical research ethics.
  • Outcome: Graduates join a global network of qualified experts eligible for roles in trial oversight committees.

Why Safety Monitoring Matters
Independent review boards like Data Safety Monitoring Boards (DSMBs) are critical for safeguarding participants and ensuring trial validity. They analyze risks, assess adverse events, and recommend protocol adjustments. Strengthening regional DSMB expertise reduces reliance on external support and accelerates Africa’s ability to respond to health crises.

Apply early to increase your chances. Follow Opportunitypool on Whatsapp and LinkedIn for real-time updates.

Curriculum Highlights

  1. Foundations of Clinical Trial Oversight
  2. Vaccine Trial Design & Risk Evaluation
  3. DSMB Decision-Making Frameworks
  4. Ethical Compliance & Regulatory Standards
  5. Statistical Tools for Interim Data Analysis
  6. Case Simulations & Collaborative Reviews

Key Benefits for Participants

  • Skill Development: Master Good Clinical Practice (GCP) alignment and risk mitigation strategies.
  • Regulatory Impact: Minimize protocol breaches through proactive monitoring.
  • Sustainability: Build self-reliant, continent-wide capacity for high-quality trials.
  • Career Advancement: Access opportunities in global DSMB panels and research consortia.

Partnerships
Delivered by Africa CDC and the Safety Platform for Emergency Vaccines (SPEAC), this program merges regional health priorities with international best practices.

Who Should Apply
Health researchers, ethicists, biostatisticians, and regulators seeking to specialize in trial safety.

Post-Training Pathways
Graduates gain eligibility for inclusion in the Global DSMB Roster, facilitating roles in multinational trials addressing pandemics, neglected diseases, and novel therapies.

Signup Now

Course and Trainings